Stephanie Lovell Trans Medics Group, Inc. (TMDX) insider trading activity

Stephanie Lovell is of TransMedics Group, Inc.. Currently has a direct ownership of 1,925 shares of TMDX, which is worth approximately $151,266. The most recent transaction as insider was on May 23, 2024, when has been sold 732 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.93K

0% 3M change

61.36% 12M change

Total Value Held $151,266

Stephanie Lovell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 23 2024	BUY Grant, award, or other acquisition	-	732 Added 27.55%	1,925 Common Stock
May 25 2023	BUY Grant, award, or other acquisition	-	1,193 Added 50.0%	1,193 Common Stock
Nov 23 2022	SELL Open market or private sale	$336,591 $59.5 p/Share	5,657 Reduced 100.0%	0 Common Stock
Nov 23 2022	BUY Exercise of conversion of derivative security	$270,517 $47.82 p/Share	5,657 Added 50.0%	5,657 Common Stock
Nov 22 2022	SELL Open market or private sale	$284,249 $58.01 p/Share	4,900 Reduced 100.0%	0 Common Stock
Nov 22 2022	BUY Exercise of conversion of derivative security	$181,496 $37.04 p/Share	4,900 Added 81.67%	1,100 Common Stock

Also insider at

CYCN

Cyclerion Therapeutics, Inc. Healthcare